发明名称 |
Flavivirus inhibitors and methods of their use |
摘要 |
Methods of treating, preventing, and/or ameliorating a Flavivirus infection in a subject are disclosed. The methods comprise administering to the subject a therapeutically effective amount of a Flavivirus inhibitor, e.g., a Flavivirus serine protease inhibitor. These methods are useful in treating, preventing, and/or ameliorating Flavivirus infections such as, for example, West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus. |
申请公布号 |
US8906937(B2) |
申请公布日期 |
2014.12.09 |
申请号 |
US201314033086 |
申请日期 |
2013.09.20 |
申请人 |
Georgetown University |
发明人 |
Padmanabhan Radhakrishnan;Pattabiraman Nagarajan;Mueller Niklaus;Nagarajan Kuppuswamy |
分类号 |
A61K31/47;C07D215/00;C07D401/12;C07D277/36;C07D413/12;C07D417/12;C07D417/06;C07D405/14;C07D215/26;C07D409/06;A61K31/4709 |
主分类号 |
A61K31/47 |
代理机构 |
Kilpatrick Townsend & Stockton, LLP |
代理人 |
Kilpatrick Townsend & Stockton, LLP |
主权项 |
1. A method of treating a Flavivirus infection in a subject, comprising administering to the subject a therapeutically effective amount of the compound of the following formula: or a pharmaceutically acceptable salt or prodrug thereof, wherein:
R1 is hydroxyl;R2, R3, R4, R5, and R6 are each independently selected from hydrogen, hydroxyl, substituted or unsubstituted C1-4 alkyl, substituted or unsubstituted C1-4 heteroalkyl, substituted or unsubstituted C2-4 alkenyl, substituted or unsubstituted C2-4 heteroalkenyl, substituted or unsubstituted C2-4 alkenyl, substituted or unsubstituted C2-4 heteroalkynyl, or halogen;A is B isand
R7 is hydrogen. |
地址 |
Washington DC US |